KIMBERLY HUFF: Open Payments
NPI 1528799749 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,330 in 51 payments from 12 companies in 2025. Trend: 2023 $1,461 · 2024 $2,047 · 2025 $1,330
Food & beverage: $1,330
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 24 | $869 |
| Corium, LLC | 9 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $91 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Lundbeck LLC | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| ABBVIE INC. | 2 | $27 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: ARISTADA, LYBALVI, Azstarys, CAPLYTA, Auvelity, REXULTI, SPRAVATO, VRAYLAR.
Industry payments across IN — which companies pay providers there.
